Skip to main content

Rocket Pharmaceuticals, Inc.

RCKT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001281895

In the last 90 days, Rocket Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 7 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $341.2M in total; Maverick Capital is the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Rocket Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
7 filings
4 insiders, $432.5K in total
Insiders trading
4
Net value
−$432.5K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Rocket Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Rocket Pharmaceuticals, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Wilson MartinGeneral Counsel598,489Sep 15, 202610
Shah GauravCEO1,056,594Aug 20, 20269
Stevens Christopher JamesChief Operating Officer505,784Aug 13, 20263
Chaudhuri SarbaniSee Remarks262,809Aug 13, 20263
Southwell David PDirector204,522Aug 5, 20262
Wong RoderickDirector, 10% Owner75,499Jul 6, 20261
Fong PeterDirector76,195Jul 6, 20262
Dolsten MikaelDirector67,082Jul 6, 20261
Malik Fady IbrahamDirector52,862Jul 6, 20261
Boess CarstenDirector52,862Jul 6, 20261
Militello JohnSee Remarks89,780May 28, 20268
Rizvi Syed Ali-aamirChief Medical Officer407,874Feb 13, 20262
Bjork ElisabethDirector50,000Jan 6, 20261
Schwartz Jonathan DavidSee Remarks299,064Nov 20, 20251
RTW Investments, LPDirector, 10% Owner, Other: See remarks18,188,457IndirectSep 23, 20250
Granadillo Pedro PDirector54,734Jul 18, 20250
Makker GothamDirector415,346IndirectJul 18, 20250
Pratumsuwan PiratipDirector30,000Jul 18, 20250
Ondrey AaronChief Financial Officer128,173Jul 8, 20250
Patel KinnariSee Remarks441,927May 22, 20250
White Mark AndrewSee Remarks69,140Nov 4, 20240
Yalamanchi NaveenDirector16,272,635IndirectJun 20, 20240
Woods KeithDirector–Jun 20, 20240
Garcia-Parada CarlosChief Financial Officer–Feb 16, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 15, 2026 (view filing)8:27 PM ETSep 114 daysWilson MartinGeneral CounselSSale−75.4K$3.40−$256.5K−11.2%598.5K after
Aug 20, 2026 (view filing)5:30 PM ETAug 182 daysWilson MartinGeneral CounselSSale−631$3.38−$2.13K−0.1%673.9K after
Aug 20, 2026 (view filing)5:25 PM ETAug 182 daysShah GauravCEOSSale−2.29K$3.38−$7.75K−0.2%1.06M after
Aug 17, 2026 (view filing)5:52 PM ETAug 134 daysShah GauravCEOSSale−2.84K$3.38−$9.59K−0.3%1.06M after
Aug 17, 2026 (view filing)5:50 PM ETAug 134 daysWilson MartinGeneral CounselSSale−3.49K$3.38−$11.8K−0.5%674.5K after
Aug 13, 2026 (view filing)4:15 PM ETAug 112 daysStevens Christopher JamesChief Operating OfficerSSale−36.7K$3.50−$128.3K−6.8%505.8K after
Aug 13, 2026 (view filing)4:15 PM ETAug 112 daysChaudhuri SarbaniSee RemarksSSale−4.70K$3.50−$16.4K−1.8%262.8K after
May 26, 2026 (view filing)May 215 daysShah GauravCEOSSale−55.7K$3.09−$172.1K−5.0%1.06M after
May 21, 2026 (view filing)May 192 daysShah GauravCEOSSale−2.41K$3.01−$7.25K−0.2%1.04M after
May 21, 2026 (view filing)May 192 daysWilson MartinGeneral CounselSSale−662$3.01−$1.99K−0.1%678.0K after
May 21, 2026 (view filing)May 192 daysMilitello JohnSee RemarksSSale−384$3.01−$1.16K−0.4%89.8K after
May 14, 2026 (view filing)May 131 dayWilson MartinGeneral CounselSSale−3.36K$3.61−$12.1K−0.5%678.6K after
May 14, 2026 (view filing)May 131 dayShah GauravCEOSSale−2.73K$3.61−$9.85K−0.3%1.04M after
May 14, 2026 (view filing)May 131 dayMilitello JohnSee RemarksSSale−855$3.61−$3.09K−0.9%90.2K after
May 11, 2026 (view filing)May 74 daysChaudhuri SarbaniSee RemarksSSale−17.6K$3.84−$67.8K−6.2%267.5K after
Feb 20, 2026 (view filing)Feb 182 daysMilitello JohnSee RemarksSSale−1.16K$3.34−$3.86K−1.3%91.0K after
Feb 20, 2026 (view filing)Feb 182 daysShah GauravCEOSSale−5.99K$3.34−$20.0K−0.6%1.05M after
Feb 20, 2026 (view filing)Feb 182 daysWilson MartinGeneral CounselSSale−1.38K$3.34−$4.60K−0.2%682.0K after
Feb 18, 2026 (view filing)Feb 135 daysWilson MartinGeneral CounselSSale−12.3K$3.31−$40.6K−1.8%683.4K after
Feb 18, 2026 (view filing)Feb 135 daysMilitello JohnSee RemarksSSale−3.73K$3.31−$12.3K−3.9%92.2K after
Feb 18, 2026 (view filing)Feb 135 daysShah GauravCEOSSale−12.3K$3.31−$40.6K−1.2%1.05M after
Jan 6, 2026 (view filing)Jan 24 daysBjork ElisabethDirectorPPurchase+10.0K$3.44+$34.4K+25.0%50.0K after
Nov 20, 2025 (view filing)Nov 182 daysMilitello JohnSee RemarksSSale−1.09K$2.98−$3.24K−1.6%65.9K after
Nov 20, 2025 (view filing)Nov 182 daysSchwartz Jonathan DavidSee RemarksSSale−2.54K$2.98−$7.58K−0.8%299.1K after
Nov 20, 2025 (view filing)Nov 182 daysShah GauravCEOSSale−6.28K$2.98−$18.7K−0.8%778.3K after
Nov 20, 2025 (view filing)Nov 182 daysWilson MartinGeneral CounselSSale−1.65K$2.98−$4.91K−0.4%383.8K after
Oct 16, 2025 (view filing)Oct 142 daysMilitello JohnSee RemarksSSale−28.9K$3.96−$114.6K−30.1%67.0K after4 lots
Aug 27, 2025 (view filing)Aug 27Same dayBjork ElisabethDirectorPPurchase+10.0K$3.41+$34.1K+33.3%40.0K after
Aug 20, 2025 (view filing)Aug 18-192 daysMilitello JohnSee RemarksSSale−1.06K$3.05−$3.23K−1.9%55.9K after2 lots
Aug 20, 2025 (view filing)Aug 18-192 daysSchwartz Jonathan DavidSee RemarksSSale−2.48K$3.05−$7.57K−1.1%221.6K after2 lots
Aug 20, 2025 (view filing)Aug 18-192 daysWilson MartinGeneral CounselSSale−1.59K$3.04−$4.85K−1.2%135.5K after2 lots
Aug 18, 2025 (view filing)Aug 144 daysSchwartz Jonathan DavidSee RemarksSSale−11.2K$3.02−$33.7K−4.7%224.1K after
Aug 18, 2025 (view filing)Aug 144 daysMilitello JohnSee RemarksSSale−7.04K$3.02−$21.3K−11.0%57.0K after
Aug 18, 2025 (view filing)Aug 144 daysWilson MartinGeneral CounselSSale−12.1K$3.02−$36.6K−8.1%137.1K after
Jul 8, 2025 (view filing)Jul 35 daysOndrey AaronChief Financial OfficerSSale−1.48K$2.88−$4.25K−1.1%128.2K after
May 22, 2025 (view filing)May 202 daysMilitello JohnSee RemarksSSale−357$6.45−$2.30K−0.6%64.0K after
May 22, 2025 (view filing)May 202 daysSchwartz Jonathan DavidSee RemarksSSale−801$6.45−$5.17K−0.3%235.3K after
May 22, 2025 (view filing)May 202 daysPatel KinnariSee RemarksSSale−767$6.45−$4.95K−0.2%441.9K after
May 22, 2025 (view filing)May 202 daysShah GauravCEOSSale−2.25K$6.45−$14.5K−0.3%786.8K after
May 22, 2025 (view filing)May 202 daysWilson MartinGeneral CounselSSale−587$6.45−$3.79K−0.4%149.2K after
May 20, 2025 (view filing)May 164 daysMilitello JohnSee RemarksSSale−655$6.53−$4.28K−1.0%64.4K after
May 20, 2025 (view filing)May 164 daysPatel KinnariSee RemarksSSale−1.41K$6.53−$9.20K−0.3%442.7K after
May 20, 2025 (view filing)May 164 daysSchwartz Jonathan DavidSee RemarksSSale−1.58K$6.53−$10.3K−0.7%236.1K after
May 20, 2025 (view filing)May 164 daysShah GauravCEOSSale−3.62K$6.53−$23.6K−0.5%789.1K after
May 20, 2025 (view filing)May 164 daysWilson MartinGeneral CounselSSale−946$6.53−$6.18K−0.6%149.8K after
Apr 24, 2025 (view filing)Apr 222 daysMilitello JohnSee RemarksSSale−718$7.16−$5.14K−1.1%65.0K after
Apr 14, 2025 (view filing)Apr 104 daysShah GauravCEOPPurchase+20.0K$5.08+$101.6K+2.6%792.7K after
Apr 10, 2025 (view filing)Apr 91 dayPatel KinnariSee RemarksPPurchase+21.1K$4.70+$99.2K+371.8%26.8K after
Apr 8, 2025 (view filing)Apr 44 daysOndrey AaronChief Financial OfficerSSale−7.49K$5.29−$39.6K−5.5%129.7K after
Feb 27, 2025 (view filing)May 17, 2024-Feb 25, 2025286 daysLateSchwartz Jonathan DavidSee RemarksSSale−15.1K$14.84−$224.0K−6.0%237.6K after4 lots